SCHEMBL24309593

SCHEMBL24309593

CC(C)c1ccccc1-c1cc(Oc2cc(Cl)c(N3CCN(C)CC3)cc2Cl)nc(NSc2cccc(N)c2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ EGFR P00533 2/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ BRD4 O60885 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CCNK O75909 1/20 0.30
▸ CCND3 P30281 1/20 0.30
▸ CDK9 P50750 1/20 0.30
▸ CDK6 Q00534 1/20 0.30
▸ HTR1A P08908 3/20 0.30
▸ DRD2 P14416 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309467 0.90 EGFR (0.37) EGFRBRD4CCNKCCND3CDK9
SCHEMBL24309230 0.90 EGFR (0.32) KDM4EMAPTRAD52EGFRJAK2
SCHEMBL24310457 0.90 BRD4 (0.39) EGFRBRD4CCNKCCND3CDK9
SCHEMBL24309591 0.85 HTR6 (0.37) KDM4EMAPTRAD52JAK2BRD4
SCHEMBL24309262 0.82 CDK2 (0.32) CDK9
SCHEMBL24310509 0.80 CDK2 (0.32) EGFRCDK9
SCHEMBL24309684 0.80 MET (0.34) EGFRJAK2HTR1AHTR2AHTR7
SCHEMBL24309801 0.79 DRD2 (0.31) EGFRJAK2BRD4CCNKCCND3
SCHEMBL24309736 0.78 CDK2 (0.32) CDK9
SCHEMBL26806762 0.77 HTR6 (0.38) KDM4EMAPTRAD52EGFRJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback